Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
May guide antithrombotic target selection; leaves open clinical translation pending prospective trials.
Platelets are cytoplasmatic fragments from bone marrow megakaryocytes present in blood. In this work, we review the basis of platelet mechanisms, their participation in syndromes and in arterial thrombosis, and their potential as a target for designing new antithrombotic agents. The option of new biotechnological sources is also explored.
No takes yet. Share an insight, caveat, or question.
Geraldo et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: